Literature DB >> 23637297

Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening.

A T Hesselink1, C J L M Meijer, M Poljak, J Berkhof, F J van Kemenade, M L van der Salm, M Bogaarts, P J F Snijders, D A M Heideman.   

Abstract

This study showed that the Abbott RealTime High Risk HPV assay fulfilled cross-sectional clinical equivalence and reproducibility criteria of international consensus guidelines, which indicates that this assay can be considered clinically validated for cervical cancer screening purposes.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23637297      PMCID： PMC3697677          DOI： 10.1128/JCM.00633-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

Authors:  D A M Heideman; A T Hesselink; J Berkhof; F van Kemenade; W J G Melchers; N Fransen Daalmeijer; M Verkuijten; C J L M Meijer; P J F Snijders
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

2.  Validation of high-risk HPV tests for primary cervical screening.

Authors:  C J L M Meijer; H Berkhof; D A M Heideman; A T Hesselink; P J F Snijders
Journal:  J Clin Virol       Date:  2009-11       Impact factor: 3.168

Review 3.  Nucleic acid tests for the detection of alpha human papillomaviruses.

Authors:  Mario Poljak; Jack Cuzick; Boštjan J Kocjan; Thomas Iftner; Joakim Dillner; Marc Arbyn
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

4.  HPV DNA detection and typing in cervical scrapes.

Authors:  Peter J F Snijders; Adriaan J C van den Brule; Marcel V Jacobs; René P Pol; Chris J L M Meijer
Journal:  Methods Mol Med       Date:  2005

5.  Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.

Authors:  F M Carozzi; E Burroni; S Bisanzi; D Puliti; M Confortini; P Giorgi Rossi; C Sani; A Scalisi; F Chini
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

6.  Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.

Authors:  Mario Poljak; Anja Ostrbenk; Katja Seme; Veronika Ucakar; Peter Hillemanns; Eda Vrtacnik Bokal; Nina Jancar; Irena Klavs
Journal:  J Clin Microbiol       Date:  2011-03-23       Impact factor: 5.948

7.  Principles and analytical performance of Abbott RealTime High Risk HPV test.

Authors:  Shihai Huang; Ning Tang; Wai-Bing Mak; Brian Erickson; John Salituro; Yuhong Li; Evelyn Krumpe; George Schneider; Hong Yu; John Robinson; Klara Abravaya
Journal:  J Clin Virol       Date:  2009-07       Impact factor: 3.168

8.  Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.

Authors:  Chris J L M Meijer; Johannes Berkhof; Philip E Castle; Albertus T Hesselink; Eduardo L Franco; Guglielmo Ronco; Marc Arbyn; F Xavier Bosch; Jack Cuzick; Joakim Dillner; Daniëlle A M Heideman; Peter J F Snijders
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

Review 9.  Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Authors:  Marc Arbyn; Guglielmo Ronco; Ahti Anttila; Chris J L M Meijer; Mario Poljak; Gina Ogilvie; George Koliopoulos; Pontus Naucler; Rengaswamy Sankaranarayanan; Julian Peto
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641
  9 in total
  12 in total

1.  Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.

Authors:  A T Hesselink; J Berkhof; M L van der Salm; A P van Splunter; T H Geelen; F J van Kemenade; M G B Bleeker; D A M Heideman
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

2.  The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening.

Authors:  D A M Heideman; A T Hesselink; F J van Kemenade; T Iftner; J Berkhof; F Topal; D Agard; C J L M Meijer; P J F Snijders
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

Review 3.  Triage of HPV positive women in cervical cancer screening.

Authors:  Nicolas Wentzensen; Mark Schiffman; Timothy Palmer; Marc Arbyn
Journal:  J Clin Virol       Date:  2015-11-28       Impact factor: 3.168

4.  The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.

Authors:  Ditte Ejegod; Fabio Bottari; Helle Pedersen; Maria Teresa Sandri; Jesper Bonde
Journal:  J Clin Microbiol       Date:  2016-06-15       Impact factor: 5.948

5.  Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.

Authors:  Thomas Iftner; Lisa Wang; Angelika Iftner; Barbara Holz; Juliane Haedicke-Jarboui; Nathalie Iftner; Reinhard von Wasielewski; Peter Martus; Gerd Boehmer
Journal:  BMC Infect Dis       Date:  2016-11-11       Impact factor: 3.090

6. 

Authors: 
Journal:  J Virus Erad       Date:  2017-10-23

7.  Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening.

Authors:  Marion Saville; Farhana Sultana; Michael J Malloy; Louiza S Velentzis; Michael Caruana; Ellen L O Ip; Marco H T Keung; Karen Canfell; Julia M L Brotherton; David Hawkes
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

8.  Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity.

Authors:  A Mitra; D A MacIntyre; Y S Lee; A Smith; J R Marchesi; B Lehne; R Bhatia; D Lyons; E Paraskevaidis; J V Li; E Holmes; J K Nicholson; P R Bennett; M Kyrgiou
Journal:  Sci Rep       Date:  2015-11-17       Impact factor: 4.379

9.  Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population.

Authors:  Pamela Moussavou-Boundzanga; Ismaël Hervé Koumakpayi; Ingrid Labouba; Eric M Leroy; Ernest Belembaogo; Nicolas Berthet
Journal:  Virol J       Date:  2017-12-21       Impact factor: 4.099

10.  Analytical performance of a low-cost multiplex polymerase chain reaction human papillomavirus genotyping assay for use in Sub-Saharan Africa.

Authors:  Kandali Samwel; Crispin Kahesa; Julius Mwaiselage; Daniela Gonzalez; John T West; Charles Wood; Joel Palefsky; Peter C Angeletti
Journal:  J Med Virol       Date:  2018-10-22       Impact factor: 2.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.